Divi's Laboratories, India’s second-largest pharma company by market cap, is expected to report impressive revenue and profit ...

Jefferies upgradeed Gland Pharma to hold, as it believe earnings downcycle for the company is behind and in next 1-2 years can benefit from the generic GLP driven tailwinds ...